The adverse reactions listed as follows have been reported at frequencies corresponding to: very common; common; uncommon; rare; very rare and undetermined frequency (cannot be estimated on the basis of the available data).
Hepatobiliary disorders: Very rare: cytolytic hepatitis.
Investigation: Undetermined frequency: elevated transaminases, alkaline phosphatase, and bilirubin.
Skin and subcutaneous tissue disorders: Undetermined frequency: angioedema, skin rash, urticaria, and pruritus.
Immune system disorders: Very rare: anaphylactic type reactions, and anaphylactic shock.
Ear and labyrinth disorders: Undetermined frequency: vertigo.
Nervous system disorders: Undetermined frequency: headache.
Gastrointestinal disorders: Undetermined frequency: nausea.